Evommune EVMN
NYSE EVMN
$5.18 -0.20 (-3.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

Evommune (EVMN) Assets (2024 - 2026)

Updated

Evommune (EVMN) posted Assets of $301.95 million for Q2 2026, down 6.4% from the prior quarter.

Analysis

Evommune (EVMN) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Assets came in at $224.95 million, up 195.8% from FY2024.

  • In prior years, Evommune's Assets was $76.06 million in FY2024.
  • Quarterly Assets has run from a low of $76.06 million in Q4 2024 to a high of $322.46 million in Q1 2026 over five years.
  • According to Business Quant data, Assets for the three prior quarters was $322.46 million (Q1 2026), $224.95 million (Q4 2025) and $84.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Evommune 186.46 Mn -451.06 Mn - 301.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 301.95 Mn
Mar 31, 2026 322.46 Mn
Dec 31, 2025 224.95 Mn
Sep 30, 2025 84.54 Mn
Dec 31, 2024 76.06 Mn
API Access

Evommune Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=EVMN&period=max&api_key=YOUR_API_KEY